Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06235359

Is Intercostal Tube Enough in Management of Empyema

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Is intercostal tube enough in management of empyema ?

Detailed description

Empyema refers to presence of pus in the pleural space -Causes Primary: bacterial Pneumonia (staph aureus, strept pneumonia , H.influenza) , TB Secondry : PostTraumati postoperative :open heart , esophageal, mediastinum , lung rupture of lung absess -pathophysiology and stages During an inflammatory process such as pneumonia, there is an increase in fluid production in the pleural cavity known as the exudate stage. As the disease progresses microorganisms, usually bacteria, can colonize the fluid and generated an empyema. This fluid is characterized by elevated lactate dehydrogenase, proteins, neutrophils, and dead cells. Macroscopically is a thick opaque fluid found in the fibrinopurulent stage. After the resolution of the infection and as a consequence of the inflammation, there is a process of fibrosis that can lead to restriction of the lung parenchyma which is stage of chronic organization

Conditions

Interventions

TypeNameDescription
DEVICEintercostal tubeA chest tube is a hollow, flexible tube placed into the chest. It acts as a drain. Chest tubes drain blood, fluid, or air from around your lungs, heart, or esophagus. The tube around your lung is placed between your ribs and into the space between the inner lining and the outer lining of your chest cavity. This is called the pleural space. It allows your lungs to fully expand.

Timeline

Start date
2024-03-01
Primary completion
2026-11-01
Completion
2026-12-01
First posted
2024-01-31
Last updated
2024-01-31

Source: ClinicalTrials.gov record NCT06235359. Inclusion in this directory is not an endorsement.